Neurology Central

Huntington’s pathology alleviated by CRISPR/Cas9 gene editing

An international team of researchers has utilized CRISPR/Cas9 gene editing to reverse Huntington’s disease (HD) pathology in a mouse model. The findings could open up new treatment avenues for HD and other inherited neurodegenerative diseases.
To view restricted content, please:

Leave A Comment